The advancing research highlights the need for plasma donations from those who have recovered from COVID-19.

According to the CoVIg-19 Plasma Alliance, which includes co-founder Takeda and other leading plasma companies, the first patient is being treated with CoVIg-19, a hyperimmune globulin (H-Ig) medicine that is manufactured at Takeda and other sites from plasma donated by people who have fully recovered from COVID-19. This convalescent plasma contains antibodies against the virus.

https://www.rockdalenewtoncitizen.com/news/plasma-therapy-manufactured-at-takeda-in-clinical-trial-as-treatment-for-covid-19-plasma-donations/article_13693780-122c-11eb-97d2-235430927359.html